Company description:
Considering applying for this job Do not delay, scroll down and make your application as soon as possible to avoid missing out.
OXB is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, OXB has more than 30 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
OXB collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
Job description:
Join Us in Changing Lives
At?OXB, our people are at the heart of everything we do.Wereon a mission to enable life-changing therapies to reach patients around the worldandwerelooking for passionate individuals who embody our core values every day:?Responsible, Responsive, Resilient, and Respectful.
We are currently recruiting for aWarehouse Controller to join the Warehouse and Supply Chain (WSC) team at our facility in Cowley. In this role, you will carry out all the necessary activities to support the warehouse end to end function, playing a key part in advancing our mission and making a real difference.
Your responsibilities in this role would be:
* Receiving stock from vendors, ensuring product is:
o Delivered without damage
o At correct location address and matches purchase order
o Stored in appropriate location (noting any special temperature/hazardous storage conditions)
* Ensuring stock is in correct storage areas (Quarantine; Release; Reject)
* Updating of computer system where applicable to ensure accuracy
* Ensuring accuracy of stock is maintained by performing cycle counting/stock checks
* Ensuring cleanliness, safety and security of warehouse is always maintained
* Maintaining and updating Standard Operating Procedures to reflect current practices
* Picking, packing and checking stock by item, batch number and quantity as requisition
* Driving company vehicle to deliver requisitions to production and OXB (Oxford Biomedica) sites
* Co-ordinating shipments of Drug Substance (other) for ongoing processing
* Raising purchase requisitions where appropriate
We are looking for:
* High degree of accuracy, numeracy, and literacy
* Computer literacy (Word, Excel & Microsoft Outlook & Teams)
* Previous warehouse experience essential
* Manual handling trained
* Experienced in operating mechanical lifting (FLT not essential)
* Driving licence essential
About Us:
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than30years of experience in viral vectors; the driving force behindthe majority ofgene therapies.
OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXBs world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
Why Join Us?
* ???Competitive total reward packages
* ???Wellbeing programmes?that support your mental and physical health
* ???Career development opportunities?to help you grow and thrive
* ???Supportive, inclusive, and collaborative culture
* ???State-of-the-art labs and manufacturing facilities
* ??A company that lives its values:?Responsible, Responsive, Resilient, Respect
We want you to feel inspired every day. AtOXB,werefuture-focused and growing fast. We succeed togetherthrough passion, commitment, and teamwork.
Ready to Make a Difference?
Collaborate. Contribute. Change lives.
We offer:
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. xsngvjr These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.